Provided by Tiger Trade Technology Pte. Ltd.

bioAffinity Technologies, Inc.

8.75
+3.4063.55%
Post-market: 9.200.4500+5.14%19:59 EDT
Volume:25.41M
Turnover:212.70M
Market Cap:5.26M
PE:-0.08
High:11.00
Open:7.00
Low:6.45
Close:5.35
52wk High:109.35
52wk Low:4.56
Shares:600.70K
Float Shares:593.10K
Volume Ratio:48.29
T/O Rate:4284.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-103.3536
EPS(LYR):-129.9452
ROE:-1860.15%
ROA:-125.11%
PB:1.39
PE(LYR):-0.07

Loading ...

bioAffinity Technologies and Avmedical Announce Nationwide Federal Healthcare Distribution Agreement for Cypath® Lung

THOMSON REUTERS
·
Aug 18

BioAffinity Technologies announces closing of $4M private placement offering

TIPRANKS
·
Aug 16

bioAffinity Technologies Closes $4 Million Private Placement of Pre-Funded Warrants Priced at $0.47

Reuters
·
Aug 14

bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Aug 14

bioAffinity Technologies Prices USD 4 Million Private Placement at USD 0.47 Per Share Unit

Reuters
·
Aug 13

bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Aug 13

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Reuters
·
Aug 10

bioAffinity Technologies Q2 Net Income USD -3.4 Million

THOMSON REUTERS
·
Aug 07

bioAffinity Technologies Q2 EPS $(0.64) Beats $(2.40) Estimate, Sales $1.511M Beat $1.483M Estimate

Benzinga Earnings
·
Aug 07

bioAffinity Q2 FY26 Net Loss Narrows to $3.4 Million; Revenue Rises 19% to $1.5 Million

Reuters
·
Aug 07

Press Release: bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath(R) Lung

Dow Jones
·
Aug 07

bioAffinity Technologies Faces NASDAQ Delisting Risk After Shares Trade Below $1 Bid-price Minimum

Reuters
·
Aug 01

BioAffinity announces publication of clinical review on CyPath Lung

TIPRANKS
·
Jul 27

bioAffinity Publishes Clinical Framework Targeting Pulmonary Nodule Risk Stratification Market

Reuters
·
Jul 27

Bioaffinity Technologies - Tests Expected to be Offered as Laboratory Developed Tests Under Clia

THOMSON REUTERS
·
Jul 22

Bioaffinity Technologies - Partners with Pictor to Develop Asthma and Copd Diagnostics

THOMSON REUTERS
·
Jul 22

Bioaffinity Quarterly Cypath Lung Test Sales Double, up More than 200% Year over Year

Reuters
·
Jul 07

Bioaffinity to Join Navref-hosted Webinar on Philips-led US Veterans Lung Screening Program

Reuters
·
Jul 01

BioAffinity will present preclinical findings on small interfering RNAs

TIPRANKS
·
Jun 22

bioAffinity reports positive preclinical data for siRNA therapy targeting squamous, basal skin cancer cells

Reuters
·
Jun 22